Bipolar disorders
2020 · The Lancet · 935 citations
https://doi.org/10.1016/s0140-6736(20)31544-0
E
Elisa Brietzke
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
391
Papers
18.9K
Citations
69
h-index
256
i10-index
Elisa Brietzke is an academic researcher. The author has contributed to research in topics: Tryptophan and brain disorders & Bipolar Disorder and Treatment & Stress Responses and Cortisol. The author has an h-index of 69, co-authored 333 publications.
ORCID: 0000-0003-2697-1342Papers by this author
worksSynthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
2021 · American Journal of Psychiatry · 647 citations
https://doi.org/10.1176/appi.ajp.2020.20081251
Stress, epigenetics and depression: A systematic review
2019 · Neuroscience & Biobehavioral Reviews · 436 citations
https://doi.org/10.1016/j.neubiorev.2019.04.010
Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review
2018 · Journal of Affective Disorders · 397 citations
https://doi.org/10.1016/j.jad.2018.08.073
Cognitive impairment in major depressive disorder
2018 · CNS Spectrums · 278 citations
https://doi.org/10.1017/s1092852918001207
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes
2024 · The Canadian Journal of Psychiatry · 247 citations
https://doi.org/10.1177/07067437241245384
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat